Sfoglia per Autore
Use of deep whole transcriptome sequencing in Philadelphia-positive acute lymphoblastic leukemia (ALL) to identify novel mutated genes and aberrant gene expression and alternative splicing profiles associated with disease progression.
2010 Iacobucci, I.; Ferrarini, A.; Sazzini, M.; Lonetti, A.; Giacomelli, E.; Xumerle, L.; Ferrari, A.; Papayannidis, C.; Delledonne, M.; Martinelli, G.
HIGH-RESOLUTION PHARMACOGENETIC PROFILES OF GENES INVOLVED IN DRUG ABSORPTION, DISTRIBUTION, METABOLISM AND ELIMINATION IN ADULT PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
2010 I Iacobucci ;A Lonetti ;M Sazzini ;S Formica ;A Ferrari ;C Papayannidis ;P Garagnani ;A Boattini ;A Astolfi ;S Paolini ;D Cilloni ;MC Abbenante ;V Guadaguolo ;A Vitale ;F Pane ;S Soverini ;M Vignetti ;R Foà ;M Baccarani ;G Martinelli
Whole Transcriptome Resequencing of Paired Diagnosis-Relapse BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL) Samples Reveals the Loss of Cell Cycle Regulation as the Main Mechanism Responsible for Leukemia Progression
2010 I. Iacobucci; A. Lonetti; A. Ferrarini; M. Sazzini; A. Ferrari; C. Papayannidis; S. Soverini; E. Giacomelli; L. Xumerle; V. Guadagnuolo; A. Vitale; F. Pane; M. Baccarani; M. Delledonne; G. Martinelli
The Inactivation of the Tumor Suppressor Genes CDKN2A/ARF by Genomic Deletions Frequently Occurs and Worsens Prognosis In Adult BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL) Patients
2010 Iacobucci I; Ferrari A; Lonetti A; Papayannidis C; Guadagnuolo V; Ottavini E; Abbenante M; Cattina F; Vitale A; Paolini S; Soverini S; Parisi S; Paoloni F; Castagnetti F; Vignetti M; Foà R; Baccarani M; Martinelli G.
First Line Treatment with Nilotinib 800 Mg Daily Results In Unprecedentedly High Rate of Rapid, “Deep” and Stable Molecular Responses as Assessed by a High Sensitive Nanofluidic Array for the Detection of Rare Copies of BCR-ABL1 Transcript: Results of a Phase 2 Trial of the GIMEMA CML Working Party.
2010 Martinelli G; Poerio A; Amabile M; Iacobucci I; Soverini S; Castagnetti F; Palandri F; Gugliotta G; Cappucci A; Tiribelli M; Stagno F; Zaccaria A; Intermesoli T; Martino B; Bocchia M; Cedrone M; Testoni N; Breccia M; Alimena G; Levato L; Papayannidis C; Lonetti A; Terragna C; Russo D; Pane F; Saglio G; Rosti G; Baccarani M
The PAX5gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemiabut is not associated with outcome. A report on behalf of the GIMEMA AcuteLeukemia Working Party
2010 Iacobucci I; Lonetti A;Paoloni F; Papayannidis C; Ferrari A; Storlazzi CT; Vignetti M; Cilloni D;Messa F; Guadagnuolo V; Paolini S; Elia L; Messina M; Vitale A; Meloni G;Soverini S; Pane F; Baccarani M; Foà R; Martinelli G
FLUDARABINE, CYTARABINE, IDARUBICIN AND ETOPOSIDE (FLAIE) SCHEDULE IS SAFE AND ACTIVE FOR YOUNG PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: RESULTS OF A MULTICENTRIC PHASE III ITALIAN STUDY
2011 C Papayannidis ;I Iacobucci ;A Candoni ;MC Abbenante ;S Paolini ;M Malagola ;E Ottaviani ;A Lonetti ;A Curti ;S Parisi ;N Testoni ;B Lama ;M Baccarani ;G Martinelli
BCR-ABL1-Positive Acute Lymphoblastic Leukemia Patients Treated with Only TKI Vs Conventional Chemo Plus TKI Therapy Show Similar DNA Alterations At Relapse Targeting Key Regulators of Tumor Suppression, Cell Cycle Control, and Lymphoid/B-Cell Development
2011 I Iacobucci; H Pfifer; A Lonetti; C Papayannidis; A Ferrari; S Trino; M Abbenante; S Parisi; S Soverini; A Vitale; S Paolini; E Ottaviani; C Baldazzi; F Pane; M Baccarani; O G. Ottmann; G Martinelli
Nelarabine is safe and effective in adult relapsed or refractory T cellacute lymphoblastic leukemia (T-ALL) and lymphoblastic lymphoma (T-LBL): The Bologna experience
2011 Papayannidis, Cristina; Iacobucci, Ilaria; Abbenante, Mariachiara; Lonetti, Annalisa; Guadagnuolo, Viviana; Ferrrari, Anna; Ottaviani, Emanuela; Curti, Antonio; Paolini, Stefania; Parisi, Sarah; Clissa, Cristina; Baccarani, Michele; Martinelli, Giovanni
The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
2011 Ilaria Iacobucci, Federica Cattina, Silvia Pomella, Annalisa Lonetti, Enrico Derenzini, Elisa Brighenti, Anna Ferrari, Cristina Papayannidis, Maria Vittoria Verga Falzacappa, Viviana Guadagnuolo, Michela Aluigi, Emanuela Ottaviani, Serena Formica, Maria Chiara Abbenante, Simona Soverini, Domenico Russo, Fabrizio Pane, Pier Guiseppe Pellicci, Michele Baccarani, Giovanni Martinelli
MULTIPLEX PCR TO RAPIDLY IDENTIFY IKZF1 (IKAROS) GENE BREAKPOINTS IN BCRABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
2011 Ferrari A; Iacobucci I; Lonetti A; Papayannidis C; Abbenante M; Trino S; Cattina F; Guadagnuolo V; Paolini S; Parisi S; Baccarani M; Martinelli G
THE RS564398, A POLYMORPHISM IN “THE ANTISENSE NON-CODING RNA IN THE INK4 LOCUS”, ANRIL, IS ASSOCIATED TO PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) SUSCEPTIBILITY
2011 A Ferrari ;I Iacobucci ;M Sazzini ;A Lonetti ;A Boattini ;C Papayannidis ;P Garagnani ;MC Abbenante ;V Mantovani ;F Cattina ;E Marasco ;E Ottaviani ;S Paolini ;D Girelli ;M Vignetti ;F Pane ;S Soverini ;M Baccarani ;G Martinelli
PHARMACOGENOMIC PROFILE ASSOCIATED WITH HIGH SENSITIVITY AND LOW TOXICITY TO A COMBINATION OF GEMTUZUMAB OZOGAMICIN PLUS FLUDARABINE, CYTARABINE, IDARUBICIN IN CD33-POSITIVE ACUTE MYELOID LEUKEMIA
2011 I Iacobucci ;A Lonetti ;A Candoni ;M Sazzini ;S Formica ;E Ottaviani ;A Ferrari ;C Papayannidis ;A Michelutti ;E Toffoletti ;A Astolfi ;S Paolini ;MC Abbenante ;S Parisi ;F Cattina ;D Russo ;D Damiani ;F Gherlinzoni ;E Gottardi ;M Baccarani ;R Fanin ;G Martinelli
LOSS OF CDKN2A GENE IS A POOR PROGNOSTIC MARKER IN ADULT BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS
2011 Iacobucci I; Ferrari A; Papayannidis C; Lonetti A; Paoloni F; Trino S; Abbenante M; Guadagnuolo V; Ottaviani; Cattina F; Vitale A; Paolini S;Soverini S; Parisi S;Vignetti M; Baccarani M; Martinelli G
Nelarabine Is Safe and Effective In Adult Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL): The Bologna Experience
2011 C Papayannidis; I Iacobucci; M Abbenante; A Lonetti; V Guadagnuolo; A Ferrari; E Ottaviani; N Testoni; C Baldazzi; A Curti; S Parisi; C Clissa; M Baccarani; G Martinelli
Drug Resistance and Bcr-Abl Kinase Domain Mutations In Philadelphia-Positive Acute Lymphoblastic Leukemia From the Imatinib to the 2nd-Generation Tyrosine Kinase Inhibitor Era: The Main Changes Are In the Type of Mutations, but Not In the Frequency of Mutation Involvement
2011 S Soverini; A Gnani; C De Benedittis; I Iacobucci; A Lonetti; C Papayannidis; L Potenza; M Luppi; S Merante; M Malagola; D Russo; M Tiribelli; M Salvucci; A Zaccaria; B Giannini; G Poletti; A Vitale; L Elia; M Vignetti; R Foà; M Baccarani; G Martinelli
NEXT GENERATION PAIRED END TRANSCRIPTOMIC RE-SEQUENCING TECHNOLOGY REVEALS NOVEL COMMON GENETIC ALTERATIONS IN THE HEDGEHOG PATHWAY IN ADULT BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
2011 Iacobucci I; Ferrarini A; Sazzini M; Lonetti A; Ferrari A; Papayannidis C; Soverini S; Xumerle L; Guadagnuolo V; Trino S; Cattina F; Pane F; Baccarani M; Russo D; Delledonne M; Martinelli G
ARF Loss, a Negative Prognostic Factor in Philadelphia-Positive Acute Lymphoblastic Leukemia, May Be Efficiently Overcome by the Small Molecule MDM2 Antagonist RG7112
2011 I Iacobucci; F Cattina; S Pomella; A Lonetti; A Ferrari; C Papayannidis; S Trino; D Erriquez; V Guadagnuolo; E Ottaviani; S Formica; S Soverini; F Paoloni; M Vignetti; D Russo; G Perini; M Baccarani; G Martinelli
Ultra-Deep Amplicon Sequencing Using Roche 454 Technology Allows High Sensitivity Bcr-Abl Kinase Domain Mutation Screening and Anticipates Emerging Mutations Leading to Resistance to Tyrosine Kinase Inhibitors in Philadelphia-Positive Leukemia Patients
2011 Soverini S; De Benedittis C; Gnani A; Iacobucci I; Russo D; Cattina F; Castagnetti F; Gugliotta G; Papayannidis C; Vitale A; Elia L; Foà R; Palandri F; Lonetti A; Bochicchio MT; Durante S; Rosti G; Baccarani M; Martinelli G
The role of the loss of CDKN2A gene on prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia (ALL)
2011 Iacobucci, I.; Ferrari, A.; Lonetti, A.; Papayannidis, C.; Paoloni, F.; Abbenante, M.; Guadagnuolo, V.; Ottaviani, E.; Cattina, F.; Vitale, A.; Paolini, S.; Soverini, S.; Parisi, S.; Vignetti, M.; Baccarani, M.; Martinelli, G.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Use of deep whole transcriptome sequencing in Philadelphia-positive acute lymphoblastic leukemia (ALL) to identify novel mutated genes and aberrant gene expression and alternative splicing profiles associated with disease progression. | Iacobucci, I.; Ferrarini, A.; Sazzini, M.; Lonetti, A.; Giacomelli, E.; Xumerle, L.; Ferrari, A.;... Papayannidis, C.; Delledonne, M.; Martinelli, G. | 2010-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
| HIGH-RESOLUTION PHARMACOGENETIC PROFILES OF GENES INVOLVED IN DRUG ABSORPTION, DISTRIBUTION, METABOLISM AND ELIMINATION IN ADULT PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS | I Iacobucci ;A Lonetti ;M Sazzini ;S Formica ;A Ferrari ;C Papayannidis ;P Garagnani ;A Boattini ...;A Astolfi ;S Paolini ;D Cilloni ;MC Abbenante ;V Guadaguolo ;A Vitale ;F Pane ;S Soverini ;M Vignetti ;R Foà ;M Baccarani ;G Martinelli | 2010-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Whole Transcriptome Resequencing of Paired Diagnosis-Relapse BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL) Samples Reveals the Loss of Cell Cycle Regulation as the Main Mechanism Responsible for Leukemia Progression | I. Iacobucci; A. Lonetti; A. Ferrarini; M. Sazzini; A. Ferrari; C. Papayannidis; S. Soverini; E. ...Giacomelli; L. Xumerle; V. Guadagnuolo; A. Vitale; F. Pane; M. Baccarani; M. Delledonne; G. Martinelli | 2010-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| The Inactivation of the Tumor Suppressor Genes CDKN2A/ARF by Genomic Deletions Frequently Occurs and Worsens Prognosis In Adult BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL) Patients | Iacobucci I; Ferrari A; Lonetti A; Papayannidis C; Guadagnuolo V; Ottavini E; Abbenante M; Cattin...a F; Vitale A; Paolini S; Soverini S; Parisi S; Paoloni F; Castagnetti F; Vignetti M; Foà R; Baccarani M; Martinelli G. | 2010-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| First Line Treatment with Nilotinib 800 Mg Daily Results In Unprecedentedly High Rate of Rapid, “Deep” and Stable Molecular Responses as Assessed by a High Sensitive Nanofluidic Array for the Detection of Rare Copies of BCR-ABL1 Transcript: Results of a Phase 2 Trial of the GIMEMA CML Working Party. | Martinelli G; Poerio A; Amabile M; Iacobucci I; Soverini S; Castagnetti F; Palandri F; Gugliotta ...G; Cappucci A; Tiribelli M; Stagno F; Zaccaria A; Intermesoli T; Martino B; Bocchia M; Cedrone M; Testoni N; Breccia M; Alimena G; Levato L; Papayannidis C; Lonetti A; Terragna C; Russo D; Pane F; Saglio G; Rosti G; Baccarani M | 2010-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| The PAX5gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemiabut is not associated with outcome. A report on behalf of the GIMEMA AcuteLeukemia Working Party |
Iacobucci I; Lonetti A;Paoloni F; Papayannidis C; Ferrari A; Storlazzi CT; Vignetti M; Cilloni D...;Messa F; Guadagnuolo V; Paolini S; Elia L; Messina M; Vitale A; Meloni G;Soverini S; Pane F; Baccarani M; Foà R; Martinelli G |
2010-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | Iacobucci_Haematologica2010.pdf; 2009.020792.Iacobucci_suppl.pdf |
| FLUDARABINE, CYTARABINE, IDARUBICIN AND ETOPOSIDE (FLAIE) SCHEDULE IS SAFE AND ACTIVE FOR YOUNG PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: RESULTS OF A MULTICENTRIC PHASE III ITALIAN STUDY | C Papayannidis ;I Iacobucci ;A Candoni ;MC Abbenante ;S Paolini ;M Malagola ;E Ottaviani ;A Lonet...ti ;A Curti ;S Parisi ;N Testoni ;B Lama ;M Baccarani ;G Martinelli | 2011-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| BCR-ABL1-Positive Acute Lymphoblastic Leukemia Patients Treated with Only TKI Vs Conventional Chemo Plus TKI Therapy Show Similar DNA Alterations At Relapse Targeting Key Regulators of Tumor Suppression, Cell Cycle Control, and Lymphoid/B-Cell Development | I Iacobucci; H Pfifer; A Lonetti; C Papayannidis; A Ferrari; S Trino; M Abbenante; S Parisi; S So...verini; A Vitale; S Paolini; E Ottaviani; C Baldazzi; F Pane; M Baccarani; O G. Ottmann; G Martinelli | 2011-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| Nelarabine is safe and effective in adult relapsed or refractory T cellacute lymphoblastic leukemia (T-ALL) and lymphoblastic lymphoma (T-LBL): The Bologna experience | Papayannidis, Cristina; Iacobucci, Ilaria; Abbenante, Mariachiara; Lonetti, Annalisa; Guadagnuolo..., Viviana; Ferrrari, Anna; Ottaviani, Emanuela; Curti, Antonio; Paolini, Stefania; Parisi, Sarah; Clissa, Cristina; Baccarani, Michele; Martinelli, Giovanni | 2011-01-01 | CANCER RESEARCH | - | 4.02 Riassunto (Abstract) | - |
| The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) | Ilaria Iacobucci, Federica Cattina, Silvia Pomella, Annalisa Lonetti, Enrico Derenzini, Elisa Bri...ghenti, Anna Ferrari, Cristina Papayannidis, Maria Vittoria Verga Falzacappa, Viviana Guadagnuolo, Michela Aluigi, Emanuela Ottaviani, Serena Formica, Maria Chiara Abbenante, Simona Soverini, Domenico Russo, Fabrizio Pane, Pier Guiseppe Pellicci, Michele Baccarani, Giovanni Martinelli | 2011-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
| MULTIPLEX PCR TO RAPIDLY IDENTIFY IKZF1 (IKAROS) GENE BREAKPOINTS IN BCRABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) |
Ferrari A; Iacobucci I; Lonetti A; Papayannidis C; Abbenante M; Trino S; Cattina F; Guadagnuolo V...; Paolini S; Parisi S; Baccarani M; Martinelli G |
2011-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| THE RS564398, A POLYMORPHISM IN “THE ANTISENSE NON-CODING RNA IN THE INK4 LOCUS”, ANRIL, IS ASSOCIATED TO PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) SUSCEPTIBILITY | A Ferrari ;I Iacobucci ;M Sazzini ;A Lonetti ;A Boattini ;C Papayannidis ;P Garagnani ;MC Abbenan...te ;V Mantovani ;F Cattina ;E Marasco ;E Ottaviani ;S Paolini ;D Girelli ;M Vignetti ;F Pane ;S Soverini ;M Baccarani ;G Martinelli | 2011-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| PHARMACOGENOMIC PROFILE ASSOCIATED WITH HIGH SENSITIVITY AND LOW TOXICITY TO A COMBINATION OF GEMTUZUMAB OZOGAMICIN PLUS FLUDARABINE, CYTARABINE, IDARUBICIN IN CD33-POSITIVE ACUTE MYELOID LEUKEMIA | I Iacobucci ;A Lonetti ;A Candoni ;M Sazzini ;S Formica ;E Ottaviani ;A Ferrari ;C Papayannidis ;...A Michelutti ;E Toffoletti ;A Astolfi ;S Paolini ;MC Abbenante ;S Parisi ;F Cattina ;D Russo ;D Damiani ;F Gherlinzoni ;E Gottardi ;M Baccarani ;R Fanin ;G Martinelli | 2011-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| LOSS OF CDKN2A GENE IS A POOR PROGNOSTIC MARKER IN ADULT BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS |
Iacobucci I; Ferrari A; Papayannidis C; Lonetti A; Paoloni F; Trino S; Abbenante M; Guadagnuolo V...; Ottaviani; Cattina F; Vitale A; Paolini S;Soverini S; Parisi S;Vignetti M; Baccarani M; Martinelli G |
2011-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Nelarabine Is Safe and Effective In Adult Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL): The Bologna Experience | C Papayannidis; I Iacobucci; M Abbenante; A Lonetti; V Guadagnuolo; A Ferrari; E Ottaviani; N Tes...toni; C Baldazzi; A Curti; S Parisi; C Clissa; M Baccarani; G Martinelli | 2011-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| Drug Resistance and Bcr-Abl Kinase Domain Mutations In Philadelphia-Positive Acute Lymphoblastic Leukemia From the Imatinib to the 2nd-Generation Tyrosine Kinase Inhibitor Era: The Main Changes Are In the Type of Mutations, but Not In the Frequency of Mutation Involvement | S Soverini; A Gnani; C De Benedittis; I Iacobucci; A Lonetti; C Papayannidis; L Potenza; M Luppi;... S Merante; M Malagola; D Russo; M Tiribelli; M Salvucci; A Zaccaria; B Giannini; G Poletti; A Vitale; L Elia; M Vignetti; R Foà; M Baccarani; G Martinelli | 2011-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| NEXT GENERATION PAIRED END TRANSCRIPTOMIC RE-SEQUENCING TECHNOLOGY REVEALS NOVEL COMMON GENETIC ALTERATIONS IN THE HEDGEHOG PATHWAY IN ADULT BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) |
Iacobucci I; Ferrarini A; Sazzini M; Lonetti A; Ferrari A; Papayannidis C; Soverini S; Xumerle L;... Guadagnuolo V; Trino S; Cattina F; Pane F; Baccarani M; Russo D; Delledonne M; Martinelli G |
2011-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| ARF Loss, a Negative Prognostic Factor in Philadelphia-Positive Acute Lymphoblastic Leukemia, May Be Efficiently Overcome by the Small Molecule MDM2 Antagonist RG7112 | I Iacobucci; F Cattina; S Pomella; A Lonetti; A Ferrari; C Papayannidis; S Trino; D Erriquez; V G...uadagnuolo; E Ottaviani; S Formica; S Soverini; F Paoloni; M Vignetti; D Russo; G Perini; M Baccarani; G Martinelli | 2011-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| Ultra-Deep Amplicon Sequencing Using Roche 454 Technology Allows High Sensitivity Bcr-Abl Kinase Domain Mutation Screening and Anticipates Emerging Mutations Leading to Resistance to Tyrosine Kinase Inhibitors in Philadelphia-Positive Leukemia Patients | Soverini S; De Benedittis C; Gnani A; Iacobucci I; Russo D; Cattina F; Castagnetti F; Gugliotta G...; Papayannidis C; Vitale A; Elia L; Foà R; Palandri F; Lonetti A; Bochicchio MT; Durante S; Rosti G; Baccarani M; Martinelli G | 2011-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| The role of the loss of CDKN2A gene on prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia (ALL) | Iacobucci, I.; Ferrari, A.; Lonetti, A.; Papayannidis, C.; Paoloni, F.; Abbenante, M.; Guadagnuol...o, V.; Ottaviani, E.; Cattina, F.; Vitale, A.; Paolini, S.; Soverini, S.; Parisi, S.; Vignetti, M.; Baccarani, M.; Martinelli, G. | 2011-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile